The global economy has slowed down remarkably lately, primarily due to the aggressive interest-rate hikes implemented by central banks in an effort to restore inflation to normal levels. As a result, ...
Tag: gsk
GSK share price gains momentum ahead of earnings: is it a buy?
GlaxoSmithKline (LON: GSK) share price has made a strong rebound recently as investors buy the company’s dip. The shares jumped to a high of 1,433p on Monday, which was the highest level since August ...
Forbes Dividend Investor Adding Coterra Energy, Dropping Tyson And GSK
Two important inflation readings last week came in lower than expected and propelled stocks higher on hopes that monthly data showing a deceleration of price increases will temper the fervor of the Fe...
Pharmaceutical Stocks GSK, Sanofi, Haleon Lose Billions As Zantac Recall Trial Looms
Pharmaceutical stocks GSK (GSK), Sanofi (SNY) and Haleon (HLN) have wiped out a combined $31 billion in market cap this week as worries mount surrounding litigation around recalled heartburn drug Zant...
FTSE 100 hits resistance ahead of BT, Lloyds, GSK, BAT, Shell earnings
The FTSE 100 index made a bullish break-out on Tuesday as investors reflected on the ongoing earnings season. The index, which is made up of the top blue-chip British companies, rose to a high of €7,3...
GSK spinoff starts trading at LSE
Monday, July 18, is set up to be a big day for GlaxoSmithKline (NYSE: GSK) and the London Stock Exchange (LSE), as the GSK consumer health unit started trading as a separate entity, under the name Hal...
GSK Spins Off $36 Billion Consumer-Healthcare Business Haleon
GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-alo...
A New Covid Vaccine That’s Effective Against Omicron Could Hit The Market This Year
Topline Sanofi and GlaxoSmithKline are hoping to launch their latest Covid vaccine later this year after trials found it to be particularly effective against the omicron variant, promising news for th...
GSK Stock: How It’s Spending Up To $3.3 Billion To Square Off With Pfizer, Merck
GlaxoSmithKline (GSK) is squaring off with Pfizer (PFE) and Merck (MRK) after announcing Tuesday a $3.3 billion deal to buy pneumonia vaccine-maker Affinivax. But GSK stock dipped at the close. X The ...
GSK Q1 highlights: ‘our results reflect further good momentum’
Shares of GlaxoSmithKline plc (LON: GSK) are up 3.0% on Wednesday after the pharmaceutical giant reported better-than-expected Q1 results on strong COVID-19 vaccine sales. GSK Q1 financial highlights ...
Late-Stage Biopharmaceutical Sierra Oncology announces acquisition by GSK
Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share in cash. That represents a total equity value of $1...
GSK Stock Eyes Breakout After Racking Up HIV Treatment Wins
GlaxoSmithKline (GSK) has racked up a series of recent HIV treatment wins and, on Monday, GSK stock flirted with a breakout. X Last month, Glaxo’s ViiV Healthcare won Food and Drug Administratio...
GSK, Vir Say Their Covid Antibody Treatment Can Neutralize Fast-Spreading Omicron Relative
Topline A Covid-19 antibody treatment developed by Vir Biotechnology and GlaxoSmithKline is still capable of neutralizing the infectious omicron subvariant, BA.2, Vir announced Thursday, offering earl...
Analysts, Markets Think Unilever’s GSK Consumer Bid Is a Bad Idea
LONDON — Bad idea. Analysts covering Unilever didn’t hold back their feelings about the group’s 50-billion-pound bid for the consumer health care division of GlaxoSmithKline, which emerged over the we...
Unilever Plans Overhaul After Bids for GSK Consumer Unit
(Bloomberg) — Unilever Plc is promising to revamp its structure and plans to sell off slow-growth brands as it weighs making a higher offer for GlaxoSmithKline Plc’s consumer unit. Most Read fro...